Figure 3.

Effect of 3 mg kg⁻¹ of PR5 injected at different time points during 10 min left coronary artery occlusion followed by 20 min reperfusion on the incidence of ventricular tachycardia (VT), fibrillation (VF) and mortality during reperfusion. Shown are saline injected animals (1 Control), animals injected with PR5 on the ninth min of occlusion (2 occlusion 9 min), animals injected with PR5 at the onset of reperfusion (3 reperfusion 0 min), animals injected with PR5 1 min after start of reperfusion (3 reperfusion 1 min), and animals injected with PR5 5 min after the start of reperfusion (5 reperfusion 5 min). (^*Indicates P<0.05).